HLHS Cause to Cure

Hypoplastic Left Heart Syndrome Program from Mayo Clinic

Share this:
March 19, 2014

American Heart Association Video Sends Message of Hope.

By jthebiay

In the video below, Joseph Dearani, M.D., chair of cardiovascular surgery at Mayo Clinic, talks about the history of miracles in medicine - from the invention of antibiotics to organ transplantation - and the need for something new to transform medicine for those with heart failure. Particularly patients with congenital heart defects. "Once the function of the ventricle goes down, we don't have anything for that. Stem cell therapy has the ability to improve the function of any of the ventricles that are failing," says Dr. Dearani.

Timothy Nelson M.D., Ph.D., discusses the first step - the clinical trial underway at Mayo Clinic using stem cells in congenital heart disease, specifically HLHS. "What we believe is that the cells are stimulating the underlying regenerative capability of the heart."

Also in the video, you will meet Roman Rubeck - an HLHS warrior who is significantly contributing to this journey in medicine.



The Todd and Karen Wanek Family Program for Hypoplastic Left Heart Syndrome (HLHS) is a collaborative network of specialists bonded by the vision of delaying or preventing heart failure for individuals affected by congenital heart defects including HLHS. The specialized team is addressing the various aspects of these defects by using research and clinical strategies ranging from basic science, to diagnostic imaging to regenerative therapies.

Tags: AHA, American Heart Association, clinical trials, Clinical Trials, Dr. Joseph Dearani, Dr. Timothy Nelson, Mayo Clinic, Patient Stories, stem cells

Please login or register to post a reply.
Contact Us · Privacy Policy